Objective: Comorbidity with attention deficit hyperactivity disorder (ADHD) and disruptive mood dysregulation disorders (DMDD) is very common in children and adolescents In this study, we aimed to present a retrospective study of methylphenidate (MPH) treatment in 12 cases who were diagnosed with DMDD and ADHD
Objective: Children with attention deficit hyperactivity disorder (ADHD) who participated in a rando...
Randomized placebo-controlled trials have reported efficacy of methylphenidate (MPH) for Attention-d...
Purpose: Individuals with attention deficit/hyperactivity disorder (ADHD) may suffer from emotional ...
Objective: Comorbidity with attention deficit hyperactivity disorder (ADHD) and disruptive mood dysr...
Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorde...
PubMed ID: 28225747Background and Aim Emotional dysregulation (ED) is a frequent feature of attentio...
WOS: 000396116100017PubMed ID: 28225747Background and Aim Emotional dysregulation (ED) is a frequent...
Emotional dysregulation (ED) is common in attention-deficit/hyperactivity disorder (ADHD). Nonethele...
Objective: The purpose of this open-label study was to examine the effects of long-acting methylphen...
This study aimed to investigate the effects of methylphenidate (MPH) on scores on a neurocognitive t...
BACKGROUND: Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperacti...
Objectives: This study examines the tolerability and efficacy of methylphenidate (MPH) and behavior ...
Objective: Children with attention deficit hyperactivity disorder (ADHD) who participated in a rando...
Background: Children with attention deficit hyperactivity disorder/developmental coordination disord...
Ipek Suzer Gamli,1 Aysegul Yolga Tahiroglu2 1Sanliurfa Education and Research Hospital, Eyyubiye, S...
Objective: Children with attention deficit hyperactivity disorder (ADHD) who participated in a rando...
Randomized placebo-controlled trials have reported efficacy of methylphenidate (MPH) for Attention-d...
Purpose: Individuals with attention deficit/hyperactivity disorder (ADHD) may suffer from emotional ...
Objective: Comorbidity with attention deficit hyperactivity disorder (ADHD) and disruptive mood dysr...
Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperactivity disorde...
PubMed ID: 28225747Background and Aim Emotional dysregulation (ED) is a frequent feature of attentio...
WOS: 000396116100017PubMed ID: 28225747Background and Aim Emotional dysregulation (ED) is a frequent...
Emotional dysregulation (ED) is common in attention-deficit/hyperactivity disorder (ADHD). Nonethele...
Objective: The purpose of this open-label study was to examine the effects of long-acting methylphen...
This study aimed to investigate the effects of methylphenidate (MPH) on scores on a neurocognitive t...
BACKGROUND: Methylphenidate (MPH) is the most common drug treatment of attention deficit / hyperacti...
Objectives: This study examines the tolerability and efficacy of methylphenidate (MPH) and behavior ...
Objective: Children with attention deficit hyperactivity disorder (ADHD) who participated in a rando...
Background: Children with attention deficit hyperactivity disorder/developmental coordination disord...
Ipek Suzer Gamli,1 Aysegul Yolga Tahiroglu2 1Sanliurfa Education and Research Hospital, Eyyubiye, S...
Objective: Children with attention deficit hyperactivity disorder (ADHD) who participated in a rando...
Randomized placebo-controlled trials have reported efficacy of methylphenidate (MPH) for Attention-d...
Purpose: Individuals with attention deficit/hyperactivity disorder (ADHD) may suffer from emotional ...